Platelet activation by the apoB/E receptor-binding domain of LDL

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 880-887

  Relou, Ingrid A M ^a   Gorter, G ^a   Van Rijn, H J M ^a   Akkerman, J W N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

apoB100; apoE; LDL; p38MAPK; Platelets

Indexed keywords

ANTIBODY; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PHOSPHOLIPASE A2; SYNAPTOPHYSIN;

ARTICLE; BINDING SITE; DESENSITIZATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; THROMBOCYTE ACTIVATION;

EID: 0036252997     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613100     Document Type: Article

References (42)

1. Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface
2. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins
3. Role of the lysine residues of plasma lipoproteins in high-affinity binding to cell surface receptors on human fibroblasts
4. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts
5. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100
6. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
7. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100
8. Familial defective apolipoprotein B-100: Low density lipoproteins with abnormal receptor binding
9. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells
10. Low-density lipoprotein enhances platelet secretion via integrin-αIIbβ3-mediated signaling
11. Low density lipoprotein phosphorylates the focal adhesion-associated kinase p125(FAK) in human platelets independent of integrin alphaIIb beta3
12. Enhancement of platelet functions by low density lipoproteins
13. 3 cytoplasmic domain mutants
14. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules
15. LDL binding sites on platelets differ from the "classical" receptor of nucleated cells
16. Identification and characterization of LRP8 (apoER2) in human blood platelets
17. Early platelet activation by low density lipoprotein via p38MAP kinase
18. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
19. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
20. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
21. Low density lipoprotein binding to human platelets: Role of charge and of specific amino acids
22. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation
23. Characterization of monoclonal antibodies against human low density lipoprotein
24. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
25. Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. Evidence for activation of cPLA2 independent of the mitogen-activated protein kinases ERK1/2
26. Low-density lipoprotein activates the small GTPases Rap1 and Ra1 in human platelets
27. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelet inhibits agonist-induced platelet aggregation
28. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100
29. A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor
30. Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors
31. Molecular parameters that control the association of low density lipoprotein apo B-100 with chondroitin sulphate
32. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
33. Platelet LDL receptor recognizes with the same apparent affinity both oxidized and native LDL. Evidence that the receptor-ligand complexes are not internalized
34. Study of low density lipoprotein interaction with platelets by flow cytofluorimetry
35. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production
36. Platelet activation by oxidatively modified low density lipoproteins
37. Apolipoprotein E inhibits platelet aggregation through the L-arginine: Nitric oxide pathway. Implications for vascular disease
38. Human apolipoprotein B: Structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization
39. Protein kinase C-dependent desensitization of HDL3-activated phospholipase C in human platelets
40. Mechanisms for regulating platelet high density lipoprotein type 3 binding sites: Evidence that binding sites are downregulated by a protein kinase C-dependent mechanism
41. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain